about
The epigenome, 4D nucleome and next-generation neuropsychiatric pharmacogenomicsFunctional Heterogeneity in the Bed Nucleus of the Stria Terminalis.Adult neurogenesis and mental illness.Optogenetics in preclinical neuroscience and psychiatry research: recent insights and potential applications.Competent psychopharmacology.Reward function: a promising but (still) underexamined dimension in developmental psychopathology.A computer-based quantitative systems pharmacology model of negative symptoms in schizophrenia: exploring glycine modulation of excitation-inhibition balance.Adjunctive raloxifene treatment improves attention and memory in men and women with schizophrenia.Adult Hippocampal Neurogenesis, Fear Generalization, and Stress.Illuminating circuitry relevant to psychiatric disorders with optogeneticsChallenges in understanding psychiatric disorders and developing therapeutics: a role for zebrafish.Elevated baseline serum glutamate as a pharmacometabolomic biomarker for acamprosate treatment outcome in alcohol-dependent subjects.Neuronal correlates of depression.Hedonic sensitivity to low-dose ketamine is modulated by gonadal hormones in a sex-dependent mannerConcise Review: Progress and Challenges in Using Human Stem Cells for Biological and Therapeutics Discovery: Neuropsychiatric Disorders.Human neuronal changes in brain edema and increased intracranial pressureEditorial (Thematic Selection: Inflammatory and Immune Responses in Depression).Recent genetic findings in schizophrenia and their therapeutic relevanceWhite spots in pharmaceutical pipelines-EMA identifies potential areas of unmet medical needs.Importance of gene dosage in controlling dendritic arbor formation during development.Epigenetic Treatment of Neuropsychiatric Disorders: Autism and Schizophrenia.Adolescent brain development and depression: A case for the importance of connectivity of the anterior cingulate cortex.New drug developments in psychosis: Challenges, opportunities and strategies.Neuroscience and the future for mental health?Mechanisms underlying the early risk to develop anxiety and depression: A translational approach.Epigenomic mapping and effect sizes of noncoding variants associated with psychotropic drug response.Activating positive memory engrams suppresses depression-like behaviour.Depression: the best way forward.Adult zebrafish in CNS disease modeling: a tank that's half-full, not half-empty, and still filling.An in Silico, Biomarker-Based Method for the Evaluation of Virtual Neuropsychiatric Drug Effects.Comprehensive comparative analysis of 5'-end RNA-sequencing methods
P2860
Q26785674-5E072799-D9EF-4C46-9B6B-923505128277Q30364174-0AB30ABA-E3E9-4B6C-AE6C-63147C8C4E1FQ30395004-2AA34E30-05F3-4899-938E-3CD41701E812Q33968713-1943930E-1F7A-4794-B121-923C0A84F947Q34083916-552B330C-3778-4267-8BF0-D9DF87E65D89Q34139414-DC5F530A-6E78-452F-9F3A-9908E4FF7F3FQ34377319-D9F8BF32-DDB5-4323-848B-012BBD0408F7Q34476635-A55DA4F2-4604-42D9-BFC1-42E899A71E79Q34480465-68F300A3-39BA-4BFD-9442-DA5A9A2F6828Q34943448-995D93BA-CAAA-4BBD-A67B-5A79C73479DEQ35802879-E3963D7C-BC05-4758-BE27-D1CDE18FFDE2Q36043383-25E3F7BF-DFD6-4476-AD09-F6D9368CD22CQ36451816-30CBD2F4-7062-476A-BFB5-518ED37B47B5Q36616952-CF2F7183-5842-470B-AB63-BC58DF8981A6Q36717285-864EF466-3CF2-4174-9409-BFE1C49CEDBFQ37150638-07B446A5-0BF1-4C07-9F69-3D4B48A5BB2BQ37310536-653357D1-76C3-4A6C-B92D-88D68E637F6BQ38260258-3992A04B-4937-4647-8AF4-EDB0F08A4C90Q38386799-AC16F399-ACCB-4F59-B22C-984E5A291901Q38537122-B52F4CF6-6CB9-434F-851A-A5720AF6E418Q38743021-8CE9D39E-3CE3-495F-94CC-81F6809EE337Q38808603-4A278A7E-B9BD-4352-B9C4-A7BEBC33616FQ38926246-A6B63D6D-91D3-475A-9379-C3825A57129EQ38978555-68B24688-B8C1-4A4A-8D95-6A2A869413B5Q39305164-B7EBD9EA-1260-4D24-AB3C-DF0E57DFB4BAQ40573761-05AE3952-FC06-4387-B76C-7515D2337164Q40825599-50F57F31-9809-476D-8FDC-4D66916C578AQ46504314-F9B2E91E-D53D-406C-8C0E-9027BEE21C2BQ47747763-9094294A-9191-42D7-9B28-67A99A4EF4F8Q50309747-56A499C4-1EEA-4EBB-B63B-34FCF2A16E19Q56879461-EA6D7364-74FB-4F28-B2BC-2565969664BC
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Revitalizing psychiatric therapeutics.
@en
Revitalizing psychiatric therapeutics.
@nl
type
label
Revitalizing psychiatric therapeutics.
@en
Revitalizing psychiatric therapeutics.
@nl
prefLabel
Revitalizing psychiatric therapeutics.
@en
Revitalizing psychiatric therapeutics.
@nl
P2860
P356
P1476
Revitalizing psychiatric therapeutics.
@en
P2093
Steven E Hyman
P2860
P2888
P304
P356
10.1038/NPP.2013.181
P407
P577
2014-01-01T00:00:00Z